JP2021535173A5 - - Google Patents
Info
- Publication number
- JP2021535173A5 JP2021535173A5 JP2021511655A JP2021511655A JP2021535173A5 JP 2021535173 A5 JP2021535173 A5 JP 2021535173A5 JP 2021511655 A JP2021511655 A JP 2021511655A JP 2021511655 A JP2021511655 A JP 2021511655A JP 2021535173 A5 JP2021535173 A5 JP 2021535173A5
- Authority
- JP
- Japan
- Prior art keywords
- composition according
- tauroridine
- composition
- method described
- administered
- Prior art date
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862723592P | 2018-08-28 | 2018-08-28 | |
| US62/723,592 | 2018-08-28 | ||
| PCT/US2019/048579 WO2020047103A1 (en) | 2018-08-28 | 2019-08-28 | Methods and compositions for treating neuroblastoma in a juvenile mammalian body |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2021535173A JP2021535173A (ja) | 2021-12-16 |
| JPWO2020047103A5 JPWO2020047103A5 (https=) | 2022-09-02 |
| JP2021535173A5 true JP2021535173A5 (https=) | 2022-09-02 |
| JP7530351B2 JP7530351B2 (ja) | 2024-08-07 |
Family
ID=69645361
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021511655A Active JP7530351B2 (ja) | 2018-08-28 | 2019-08-28 | 若年哺乳動物の身体における神経芽細胞腫を治療するための方法および組成物 |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP3843745A4 (https=) |
| JP (1) | JP7530351B2 (https=) |
| KR (1) | KR102904381B1 (https=) |
| CN (1) | CN113164491A (https=) |
| AU (1) | AU2019330831B2 (https=) |
| CA (1) | CA3111015A1 (https=) |
| WO (1) | WO2020047103A1 (https=) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6479481B1 (en) | 1999-06-04 | 2002-11-12 | Ed. Geistlich Soehne Ag Fur Chemische Industrie | Methods and compositions for treating primary and secondary tumors of the central nervous system (CNS) |
| US7345039B2 (en) * | 1999-06-04 | 2008-03-18 | Ed. Geistlich Soehne Ag Fuer Chemische Industrie | Enhancement of effectiveness of 5-fluorouracil in treatment of tumor metastases and cancer |
| JP5027369B2 (ja) | 1999-12-06 | 2012-09-19 | ガイストリッヒ ファーマ アーゲー | 腫瘍を治療する方法 |
| ATE354380T1 (de) * | 2003-02-03 | 2007-03-15 | Polaschegg Hans-Dietrich Dr Te | Zusammensetzung zur prävention von infektionen durch subkutane prothesen |
| US20080177217A1 (en) * | 2004-05-14 | 2008-07-24 | Hans-Dietrich Polaschegg | Taurolidine Formulations and Delivery: Therapeutic Treatments and Antimicrobial Protection Against Bacterial Biofilm Formation |
| WO2013190355A1 (en) * | 2012-06-18 | 2013-12-27 | Geistlich Pharma Ag | Oxathiazine derivatives as antibacterial and anticancer agents |
| EP3402527B1 (en) | 2016-01-11 | 2022-09-28 | CorMedix Inc. | Therapeutic nanoparticles for the treatment of neuroblastoma and other cancers |
| CN106974901A (zh) * | 2016-01-18 | 2017-07-25 | 贵州益佰制药股份有限公司 | 洛铂在制备治疗神经母细胞瘤药物中的应用 |
| WO2018129061A1 (en) * | 2017-01-05 | 2018-07-12 | Cormedix Inc. | Antimicrobial delivery system for the prevention and treatment of infections in the colon |
-
2019
- 2019-08-28 AU AU2019330831A patent/AU2019330831B2/en active Active
- 2019-08-28 CA CA3111015A patent/CA3111015A1/en active Pending
- 2019-08-28 JP JP2021511655A patent/JP7530351B2/ja active Active
- 2019-08-28 WO PCT/US2019/048579 patent/WO2020047103A1/en not_active Ceased
- 2019-08-28 CN CN201980071376.2A patent/CN113164491A/zh active Pending
- 2019-08-28 KR KR1020217008970A patent/KR102904381B1/ko active Active
- 2019-08-28 EP EP19855576.5A patent/EP3843745A4/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2198196B2 (es) | Composiciones topicas que comprenden un analgesico opioide y un antagonista de nmda. | |
| RU2015144666A (ru) | Терапия для лечения рака, включающая антитела против клаудина 18.2 | |
| CN100411628C (zh) | 空间位阻的铂配位化合物与非铂抗癌剂的组合及其应用 | |
| JP2015523355A5 (https=) | ||
| Zorzi et al. | A phase I study of histone deacetylase inhibitor, pracinostat (SB939), in pediatric patients with refractory solid tumors: IND203 a trial of the NCIC IND program/C17 pediatric phase I consortium | |
| CA2412795A1 (en) | Improved liposomal camptothecins and uses thereof | |
| NZ592039A (en) | Combination therapy for the treatment of ocular neovascular disorders | |
| DK1453487T3 (da) | Farmaceutisk doseringsform med flere belægninger for reduceret virkning af belægningsbrud | |
| Hande et al. | Randomized study of high-dose versus low-dose methotrexate in the treatment of extensive small cell lung cancer | |
| JP2005008534A (ja) | 抗癌剤及び癌の治療方法 | |
| Hanada et al. | Development and pharmacological verification of a new mouse model of central post-stroke pain | |
| EE200200565A (et) | Vaskulaarse kahjustava toimega kombinatsioonravi | |
| JP2006513184A5 (https=) | ||
| AR078170A1 (es) | Metodos para el tratamiento de tumores cerebrales | |
| JP2021535163A5 (https=) | ||
| CN102438608A (zh) | 包含ave8062和索拉非尼的抗肿瘤组合 | |
| RU2011101771A (ru) | Педиатрические композиции для лечения рассеянного склероза | |
| JP2013523678A5 (https=) | ||
| JP2021535173A5 (https=) | ||
| FI3359572T3 (fi) | Menetelmä multippeliskleroosin hoitamiseksi | |
| KR20210050544A (ko) | 타우로리딘 가수분해 생성물을 이용한 신경모세포종 치료 | |
| JP2006528696A (ja) | 抗癌剤の抗腫瘍活性を増強する方法 | |
| HRP20171708T1 (hr) | FARMACEUTSKI PRIPRAVAK KOJI SADRŽI (1R,4R)-6'-FLUORO-N,N-DIMETIL-4-FENIL-4',9'-DIHIDRO-3'H-SPIRO[CIKLOHEKSAN-1,1'-PIRANO [3,4,b]INDOL]-4-AMIN I GABAPENTINOID | |
| JPWO2020047103A5 (https=) | ||
| JPH10167969A (ja) | 姑息的腫瘍療法でのドーパミンレセプター−アンタゴニストの使用 |